SCHEMBL13112151

SCHEMBL13112151

C(=C/c1ccc(-c2ccccc2)nc1)\c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 7/20 0.48
CYP11B2 P19099 7/20 0.48
LDHA P00338 1/20 0.47
GRM5 P41594 1/20 0.47
PDGFRB P09619 1/20 0.46
PDGFRA P16234 1/20 0.46
RELA Q04206 1/20 0.44
CYP3A4 P08684 1/20 0.44
NFE2L2 Q16236 1/20 0.43
CYP19A1 P11511 1/20 0.43
MAOA P21397 1/20 0.43
MAOB P27338 1/20 0.43
KDM4E B2RXH2 2/20 0.43
ALDH1A1 P00352 2/20 0.43
HPGD P15428 2/20 0.43
MITF O75030 1/20 0.43
KLF5 Q13887 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
MAPK1 P28482 1/20 0.42
MEN1 O00255 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18573204 0.90 CYP11B1 (0.46) CYP11B1CYP11B2LDHAPDGFRBPDGFRA
SCHEMBL18573186 0.90 CYP11B1 (0.46) CYP11B1CYP11B2LDHAPDGFRBPDGFRA
SCHEMBL18573398 0.87 CYP11B1 (0.46) CYP11B1CYP11B2LDHAPDGFRBPDGFRA
SCHEMBL9000479 0.87 LDHA (0.43) CYP11B1CYP11B2LDHAPDGFRBPDGFRA
SCHEMBL6656795 0.85 LDHA (0.44) CYP11B1CYP11B2LDHACYP3A4KDM4E
SCHEMBL18573318 0.82 HPGDS (0.45) CYP11B1CYP11B2LDHARELACYP3A4
SCHEMBL6655522 0.82 ALDH1A1 (0.52) CYP11B1CYP11B2LDHACYP3A4KDM4E
SCHEMBL6655528 0.82 ALDH1A1 (0.52) CYP11B1CYP11B2LDHACYP3A4KDM4E
SCHEMBL5293356 0.80 ALDH1A1 (0.62) LDHAKDM4EALDH1A1HPGDMITF
SCHEMBL5293348 0.80 ALDH1A1 (0.62) LDHAKDM4EALDH1A1HPGDMITF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1932851-B1 METAL COMPLEX, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING DEVICE SUMITOMO CHEMICAL CO (JP) 2013-06-12 EP disclosed
US-20100264812-A1 METAL COMPLEX, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING DEVICE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-10-21 US disclosed
US-20100264812-A1 METAL COMPLEX, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING DEVICE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-10-21 US disclosed
EP-1932851-A1 METAL COMPLEX, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING DEVICE Sumitomo Chemical Company, Limited (JP) 2008-06-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100264812-A1 METAL COMPLEX, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING DEVICE SOD1, CRY1, YAP1 CYP11B1 1623/4885CYP11B2 1567/4885LDHA 2025/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.